在严重的流感中预防肺部损伤
Avishekh Gautam1, David F Boyd2,3,4, Sameer Nikhar5
1Center for Immunology, Fox Chase Cancer Center, Philadelphia, PA, USA.
Nature
|April 10, 2024
概括
一种新的药物UH15-38在严重的流感A病毒感染期间有效地阻断了亡. 这种RIPK3抑制剂可以减少肺炎并防止死亡,而不会损害免疫反应或病毒清除.
科学领域:
- 病毒学
- 免疫学
- 药理学
背景情况:
- 严重的甲型流感病毒 (IAV) 感染会导致超级炎症,肺部损伤和急性呼吸困难综合征 (ARDS).
- 目前对IAV诱导的ARDS的治疗方法有限,这凸显出需要新的治疗策略.
- 细胞亡是一种编程细胞死亡形式,是严重的IAV感染中炎症和死亡的关键驱动因素,并且是RIPK3抑制剂的目标.
研究的目的:
- 评估一种新型RIPK3抑制剂UH15-38在阻断IAV诱导的亡中的有效性.
- 在IAV感染的临床前模型中评估UH15- 38在改善肺炎和预防死亡方面的治疗潜力.
主要方法:
- 对RIPK3抑制剂UH15-38的开发和表征.
- 使用实验室适应和流行性IAV菌株感染的小鼠模型的体内研究.
- 在UH15-38治疗后评估死亡,肺炎,病毒载量和免疫反应.
主要成果:
- 在膜上皮细胞中,UH15-38有力地和选择性地抑制了IAV引发的亡.
- 用UH15- 38治疗显著降低了肺炎,并预防了感染IAV的小鼠的死亡率.
- 抗病毒适应性免疫反应或病毒清除没有受到影响,即使在晚期使用时也显示出有效性.
结论:
- 通过UH15-38抑制RIPK3代表了严重流感A病毒感染的有希望的治疗策略.
- 在IAV驱动的ARDS和其他超炎症病症患者中,UH15- 38具有显著的临床益处潜力.
相关概念视频
01:28Depolarizing Blockers: Mechanism of Action
1.5K
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
1.5K
01:19Depolarizing Blockers: Pharmocokinetics
324
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
324
01:26Flail Chest-II
168
Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
Assessment:
1. Clinical Evaluation:
History:
168